CP Pharm Limited 07205311 false 2022-04-01 2023-03-31 2023-03-31 The principal activity of the company is Other human health activities. Digita Accounts Production Advanced 6.30.9574.0 true 07205311 2022-04-01 2023-03-31 07205311 2023-03-31 07205311 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 07205311 bus:Micro-entities 2022-04-01 2023-03-31 07205311 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 07205311 bus:FullAccounts 2022-04-01 2023-03-31 07205311 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 07205311 bus:RegisteredOffice 2022-04-01 2023-03-31 07205311 bus:Director1 2022-04-01 2023-03-31 07205311 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 07205311 countries:AllCountries 2022-04-01 2023-03-31 07205311 2021-04-01 2022-03-31 07205311 2022-03-31 07205311 core:CurrentFinancialInstruments core:WithinOneYear 2022-03-31 iso4217:GBP xbrli:pure

Registration number: 07205311

CP Pharm Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2023

 

CP Pharm Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

CP Pharm Limited

Company Information

Director

Ms Chandrika PATEL

Registered office

The Long Lodge
265-269 Kingston Road
Wimbledon
SW19 3NW

Accountants

Tax-Link Limited
Chartered Accountants & Tax Advisors
The Long Lodge
265-269 Kingston Road
Wimbledon
London
SW19 3NW

 

CP Pharm Limited

(Registration number: 07205311)
Balance Sheet as at 31 March 2023

2023
£

2022
£

Fixed assets

450

-

Current assets

6,639

1,317

Creditors: Amounts falling due within one year

(6,989)

(1,217)

Net current (liabilities)/assets

(350)

100

 

100

100

Capital and reserves

100

100

1

General information

The address of its registered office is:
The Long Lodge
265-269 Kingston Road
Wimbledon
SW19 3NW
United Kingdom

These financial statements were authorised for issue by the director on 16 October 2023.

Basis of preparation

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).

For the financial year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

CP Pharm Limited

(Registration number: 07205311)
Balance Sheet as at 31 March 2023

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the director on 16 October 2023
 

.........................................
Ms Chandrika PATEL
Director